liraglutide 6 MG/ML in 3 ML Pen Injector
- RxCUI
- 897122
- RxNorm name
- liraglutide 6 MG/ML in 3 ML Pen Injector
- Display name
- liraglutide 6 MG/ML in 3 ML Pen Injector
- Full name
- liraglutide 6 MG/ML in 3 ML Pen Injector
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Liraglutide | LIRAGLUTIDE | Meitheal Pharmaceuticals Inc. | 0efc3a89-211a-4496-baab-e8265e07de2b | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | NorthStar Rx LLC | 4253be3b-bda6-4efd-8118-9c9538168a88 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | Hikma Pharmaceuticals USA Inc. | 2100ec49-57b2-4330-ab5f-057ce9b7e4d0 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 897122 |
| LIRAGLUTIDE | LIRAGLUTIDE | Orbicular Pharmaceutical Technologies Private Limited | bb66a46c-9019-4a98-8e5d-581109facfba | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | Teva Pharmaceuticals USA, Inc. | 14bf9812-14ee-46ce-93b1-686e4906cbbc | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 897122 |
| LIRAGLUTIDE | LIRAGLUTIDE | Cipla USA Inc. | 8fe557ae-4ff0-47a2-8ec3-37bb0fbdcc64 | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | Lupin Pharmaceuticals, Inc. | 0450d8a2-a88e-4849-9788-ed4f5246f223 | 2025-11-13 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Victoza | LIRAGLUTIDE | Novo Nordisk | 5a9ef4ea-c76a-4d34-a604-27c5b505f5a4 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | Biocon Pharma Inc. | cb032379-043b-443c-d552-b5d25f27f3c4 | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | A-S Medication Solutions | 0ba917f7-b974-4364-a745-7494ecae3e73 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a372465-d56b-2b80-e063-6394a90a3304 | 2024-12-03 | Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a36f43f-d734-97cc-e063-6294a90ae0da | 2024-12-02 | Warnings, Adverse reactions | 897122 |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a36b801-41e2-2eed-e063-6294a90a6f27 | 2024-06-05 | Warnings, Adverse reactions | 897122 |
| Victoza | LIRAGLUTIDE | A-S Medication Solutions | 1d18f106-0584-4fee-97ab-32771a64b809 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 897122 |
| Victoza | LIRAGLUTIDE | A-S Medication Solutions | 35e613e3-7aae-4152-b827-99d1ee7841be | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 897122 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5a9ef4ea-c76a-4d34-a604-27c5b505f5a4 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 31 | These highlights do not include all the information needed to use VICTOZA ® safely and effectively. See full prescribing information for VICTOZA. VICTOZA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010 | 20251014 |
| cb032379-043b-443c-d552-b5d25f27f3c4 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 12 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20251010 |
| 0450d8a2-a88e-4849-9788-ed4f5246f223 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 10 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20251113 |
| 1d18f106-0584-4fee-97ab-32771a64b809 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 9 | These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA. VICTOZA ® (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010 | 20230206 |
| 0efc3a89-211a-4496-baab-e8265e07de2b | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 8 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20260130 |
| 2100ec49-57b2-4330-ab5f-057ce9b7e4d0 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 6 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20260330 |
| 35e613e3-7aae-4152-b827-99d1ee7841be | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 5 | These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA. VICTOZA ® (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010 | 20230206 |
| 1a372465-d56b-2b80-e063-6394a90a3304 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 4 | 20241203 | |
| 14bf9812-14ee-46ce-93b1-686e4906cbbc | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 3 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION . LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20260130 |
| 1a36f43f-d734-97cc-e063-6294a90ae0da | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 3 | 20241202 | |
| 4253be3b-bda6-4efd-8118-9c9538168a88 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 2 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20260216 |
| 8fe557ae-4ff0-47a2-8ec3-37bb0fbdcc64 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 2 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20260112 |
| bb66a46c-9019-4a98-8e5d-581109facfba | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 1 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20260312 |
| 0ba917f7-b974-4364-a745-7494ecae3e73 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 1 | These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION . LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010 | 20250130 |
| 1a36b801-41e2-2eed-e063-6294a90a6f27 | liraglutide 6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML liraglutide 6 MG/ML Pen Injector [SCD] · liraglutide 18 MG per 3 ML Pen Injector [SY] | 3 | 1 | 20240605 |